Adam P. Dommer

Statistics

Publications

Citations

H-Index

Active since

2025

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Adam P. Dommer is an author at Roswell Park Comprehensive Cancer Center specializing in cdk inhibitors, cyclin-dependent kinase inhibitors, and cell-cycle regulation.

ORCID

Publications per year

2025–2025

Publications

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle

Vishnu Kumarasamy, Jianxin Wang, Michelle Roti et al. · Nature Communications · 2025 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222

Adam P. Dommer, Vishnu Kumarasamy, Jianxin Wang et al. · Cancer Research · 2025 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +15

1–2 of 2